Pilot study of topical dinitrochlorobenzene (DNCB) in human immunodeficiency virus infection
- 30 April 1993
- journal article
- Published by Elsevier in Immunology Letters
- Vol. 36 (1) , 1-6
- https://doi.org/10.1016/0165-2478(93)90060-f
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Dendritic cells are potent antigen-presenting cells for microbial superantigens.The Journal of Experimental Medicine, 1992
- Reduction in plasma human immunodeficiency virus ribonucleic acid after dideoxynucleoside therapy as determined by the polymerase chain reaction.Journal of Clinical Investigation, 1991
- Dendritic cells and dinitrochlorobenzene (DNCB): a new treatment approach to AIDSImmunology Letters, 1991
- THE DETECTION OF HUMAN IMMUNODEFICIENCY VIRUS DNA IN DENDRITIC CELLS FROM THE JOINTS OF PATIENTS WITH ASEPTIC ARTHRITISRheumatology, 1990
- Dendritic cells in contact sensitivityResearch in Immunology, 1989
- ATPase and Morphologic Changes in Langerhans Cells Induced by Epicutaneous Application of a Sensitizing Dose of DNFB.Journal of Investigative Dermatology, 1989
- Role of epidermal Langerhans cells in viral infectionsArchiv für die gesamte Virusforschung, 1988
- Changes in Lymphocyte and Langerhans Cell Populations in Allergic and Irritant Contact DermatitisInternational Journal of Dermatology, 1987
- Epidermal Langerhans Cells-A Target for HTLV-III/LAV InfectionJournal of Investigative Dermatology, 1987
- Therapeutic Effect of Dinitrochlorobenzene (DNCB) on Verruca Plana and Verruca VulgarisInternational Journal of Dermatology, 1984